Effect of rosuvastatin on arterial function and subclinical atherosclerosis in patients with heterozygous familial hypercholesterolemia

被引：0
|
作者：
Masoura, Constantina [1 ]
Skoumas, Ioannis [1 ]
Pitsavos, Christos [1 ]
Aznaouridis, Konstantinos [1 ]
Vlachopoulos, Charalambos [1 ]
Papadimitriou, Lampos [1 ]
Raftopoulou, Stavroula [1 ]
Giotsas, Nikolaos [1 ]
Stefanadis, Christodoulos [1 ]
机构：
[1] Hippokrateion Hosp, Athens, Greece
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2008年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P535
引用
收藏
页码：E130 / E130
页数：1
相关论文
共 50 条
  • [1] Arterial characteristics in patients with heterozygous familial hypercholesterolemia: effect of rosuvastatin
    Masoura, C.
    Pitsavos, C.
    Skoumas, I.
    Aznaouridis, K.
    Vlachopoulos, C.
    Papadimitriou, L.
    Raftopoulou, S.
    Giotsas, N.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 615 - 615
  • [2] Imaging biomarkers to track subclinical atherosclerosis in heterozygous familial hypercholesterolemia
    Miname, Marcio H.
    Santos, Raul D.
    CLINICAL LIPIDOLOGY, 2013, 8 (02) : 231 - 242
  • [3] Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia
    Merran Macpherson
    Bengt Hamrén
    Marjet J. A. M. Braamskamp
    John J. P. Kastelein
    Torbjörn Lundström
    Paul D. Martin
    European Journal of Clinical Pharmacology, 2016, 72 : 19 - 27
  • [4] Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia
    Macpherson, Merran
    Hamren, Bengt
    Braamskamp, Marjet J. A. M.
    Kastelein, John J. P.
    Lundstrom, Torbjorn
    Martin, Paul D.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (01) : 19 - 27
  • [5] Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia
    Stein, EA
    Strutt, K
    Southworth, H
    Diggle, PJ
    Miller, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (11): : 1287 - 1293
  • [6] ASSESSMENT OF SUBCLINICAL CORONARY ATHEROSCLEROSIS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH MULTISLICE COMPUTED TOMOGRAPHY
    Franco, M.
    Carreras, F.
    Leta, R.
    Duran, A.
    Pons-Llado, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 25 - 25
  • [7] Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
    Neefjes, Lisan A.
    ten Kate, Gert-Jan R.
    Rossi, Alexia
    Nieman, Koen
    Galema-Boers, Annette J.
    Langendonk, Janneke G.
    Weustink, Annick C.
    Mollet, Nico R.
    Sijbrands, Eric J.
    Krestin, Gabriel P.
    de Feyter, Pim J.
    ATHEROSCLEROSIS, 2011, 219 (02) : 721 - 727
  • [8] Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment
    Miname, Marcio H.
    Bittencourt, Marcio S.
    Nasir, Khurram
    Santos, Raul D.
    CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (02) : 82 - 87
  • [9] Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia
    Antonio Gallo
    Reed Mszar
    Marcio Hiroshi Miname
    Current Atherosclerosis Reports, 2022, 24 : 407 - 418
  • [10] Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia
    Gallo, Antonio
    Mszar, Reed
    Miname, Marcio Hiroshi
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (06) : 407 - 418
12345